Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
Holding KZR?
Track your performance easily

Kezar Life Sciences (KZR) Income Statement

467 Followers

Kezar Life Sciences Income Statement

Last quarter (Q2 2024), Kezar Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Kezar Life Sciences's net income was $-21.55M. See Kezar Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 7.00M$ 7.00M----
Cost of Revenue
------
Gross Profit
$ 7.00M$ 7.00M----
Operating Expense
$ 108.02M$ 112.24M$ 71.16M$ 54.66M$ 42.95M$ 37.34M
Operating Income
$ -107.21M$ -111.42M$ -71.16M$ -54.66M$ -42.95M$ -37.34M
Net Non Operating Interest Income Expense
$ 8.64M$ 9.55M$ 2.92M$ 29.00K$ 1.21M$ 2.25M
Other Income Expense
$ -6.19M$ -6.19M----
Pretax Income
$ -98.57M$ -101.87M$ -68.24M$ -54.63M$ -41.74M$ -35.09M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -98.57M$ -101.87M$ -68.24M$ -54.63M$ -41.74M$ -35.09M
Basic EPS
$ -1.35$ -1.40$ -10.10$ -10.40$ -9.50$ -18.40
Diluted EPS
$ -1.35$ -1.40$ -10.10$ -10.40$ -9.50$ -18.40
Basic Average Shares
$ 291.07M$ 72.55M$ 6.74M$ 5.28M$ 4.40M$ 1.91M
Diluted Average Shares
$ 291.07M$ 72.55M$ 6.74M$ 5.28M$ 4.40M$ 1.91M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 114.21M$ 112.24M$ 71.16M$ 54.66M$ 42.95M$ 37.34M
Net Income From Continuing And Discontinued Operation
$ -98.57M$ -101.87M$ -68.24M$ -54.63M$ -41.74M$ -35.09M
Normalized Income
$ -51.79M$ -68.68M----
Interest Expense
------
EBIT
$ -96.97M$ -100.32M$ -67.05M$ -54.47M$ -41.74M$ -35.09M
EBITDA
$ -94.31M$ -99.25M$ -66.03M$ -52.96M$ -40.20M$ -34.77M
Currency in USD

Kezar Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis